Advertisement
Loading...

Athenex, Inc.

ATNXNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.20
$0.00(0.00%)
U.S. Market opens in 28h 24m

Athenex, Inc. (ATNX) Stock Overview

Explore Athenex, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.3M
P/E Ratio-0.01
EPS (TTM)$-10.45
ROE0.22%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

ATNX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Athenex, Inc. (ATNX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.01 and a market capitalization of 2.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-23.39%
3-Month Change
-84.38%
6-Month Change
-93.44%
Year-to-Date (YTD) Change
-94.16%
1-Year Change
-98.12%
3-Year Change
-99.92%
5-Year Change
-99.95%
All-Time (Max) Change
-99.92%

Contact Information

716 427 2950
Conventus Building, Buffalo, NY, 14203

Company Facts

2,690 Employees
IPO DateJun 14, 2017
CountryUS

Frequently Asked Questions